A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Clinical trial NCT07636785 · RECRUITING

Trial details

NCT number: NCT07636785
Sponsor: VM Discovery, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)Metastatic Uveal Melanoma Renal Cell Carcinoma (RCC)Nonsmall Cell Lung Cancer Colorectal Cancer (CRC)

Start date: 2026-07-16
Primary completion: 2031-05-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.